TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
AUTL

Autolus Therapeutics plc

Healthcare · Biotechnology

1.80$ -2.2% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Balance Sheet

Autolus Therapeutics plc (AUTL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 493 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AUTL
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
34 – – 149 149 143 143 143 273 254 264 346 315 304 338 311 317 294 350 331 297 406 364 314 264 490 460 451 406 375 901 854 827 783 746 721 662 589 527 493
31 – – 142 142 132 132 132 259 233 211 293 260 249 281 249 229 194 288 270 236 347 309 259 212 426 394 353 306 275 803 757 718 661 616 574 515 436 369 336
28 – – 137 137 121 121 121 247 217 188 266 229 211 244 213 178 154 239 216 173 310 269 216 163 382 343 308 257 240 760 707 657 227 96 124 86 104 131 171
– – – 137 137 – 121 121 247 217 188 266 229 211 244 213 178 154 239 216 173 310 269 216 163 382 343 308 257 240 760 707 657 588 517 454 367 301 229 202
2.1 – – – 4.7 – – 9.3 9.3 13 20 23 25 31 31 32 43 30 39 44 54 0.1 0.1 0.1 2.1 0.2 0.1 38 42 1.0 31 37 1.0 48 14 79 91 76 86 44
– – – – – – – – – – – – – 7.8 6.0 4.7 7.3 – – 8.7 9.8 10 9.0 5.6 7.8 14 2.3 9.6 9.9 -25 – -37 – 4.1 15 24 28 33 33 33
3.3 – – – 6.2 12 12 14 14 20 51 51 53 52 54 56 82 90 55 55 53 52 48 49 46 58 – 91 94 – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – – – – 0.0 – – – – – – – – – – – – – – –
9.5 – – – 7.3 – – 0.4 0.4 0.4 – – – 0.3 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 – – – – – – – – 12 12 13 20 20 19 19
3.5 – – 5.0 5.0 16 16 16 17 22 46 48 45 49 50 52 80 84 50 47 52 92 93 99 103 192 193 222 226 264 319 326 351 355 375 375 396 411 418 418
2.7 – – 5.0 5.0 16 16 16 17 21 20 22 21 25 26 27 31 34 31 28 35 29 29 36 39 46 40 41 38 45 44 41 52 61 67 68 83 73 64 69
– – – – – – – – – 1.7 1.7 1.9 2.3 2.5 2.5 3.9 3.4 3.6 3.7 3.9 4.5 4.5 4.2 4.0 3.8 5.0 4.8 6.2 5.5 5.1 4.8 4.2 3.6 3.0 3.0 3.3 4.8 15 3.1 5.8
1.4 – – 1.9 1.9 3.6 3.6 3.6 3.0 2.0 1.6 0.5 2.7 1.1 1.1 0.6 2.0 2.3 2.3 1.1 0.0 0.4 0.2 0.2 0.3 0.5 0.4 3.9 0.7 0.1 1.4 1.1 1.4 2.0 4.5 5.4 11 3.1 1.9 1.4
– – – – – – – – – – 26 – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
31 – – 143 143 127 127 127 255 233 218 298 270 255 287 259 237 210 300 284 245 313 271 215 161 299 267 229 181 111 582 528 477 427 371 346 265 178 109 75
-15 – – -48 -48 -72 -72 -72 -93 -113 -140 -169 -196 -237 -267 -299 -336 -379 -413 -446 -480 -521 -558 -600 -643 -670 -710 -756 -801 -879 -931 -990 -1,072 -1,099 -1,169 -1,217 -1,296 -1,387 -1,458 -1,497
– 12 12 16 16 – 29 29 39 39 39 44 45 50 50 52 52 62 62 71 73 73 91 91 91 117 174 174 174 174 222 266 266 266 266 266 266 266 266 266

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?